Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Millennium Pharmaceuticals acquires ChemGenics in stock-deal

Executive Summary

Millennium Pharmaceuticals (genomics for diagnostics and therapeutics) will acquire privately-held ChemGenics Pharmaceuticals (drug discovery) in a stock-swap transaction valued at about $89mm. ChemGenics had 1996 revenues of $3.6mm and a net loss of $12mm, according to a Millennium 8K.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies